Scott T. Mcmillan

Biography

  Dr. Scott T. McMillan, Ph.D. has been Chief Operating Officer at uniQure N.V. since August 7, 2017. Dr. McMillan is responsible for all current Good Manufacturing Process (cGMP) activities at uniQure and all product development functions. Dr. McMillan served as a Senior Vice President of Quality & Technical Operations at AMAG Pharmaceuticals, Inc., since January 2013. He joined AMAG in March 2008 as Executive Director of Manufacturing Operations and served as its Head of Quality and Vice President of Technical Operations since March 2010. He has more than 25 years of biotechnology experience in quality, process development, scale-up, technology transfer from bench to commercial scale as well as manufacturing operations for a variety of active pharmaceutical ingredients and finished drug products including small molecules, proteins, antibodies and vaccines. He served at AVANT Immunotherapeutics, Inc. Dr. McMillan served as Senior Director of Manufacturing Operations/Process Development at Celldex Therapeutics, Inc. Prior to 2005, he served as Director of Purification Operations at Johnson Matthey Pharmaceutical Materials, Inc. Since 2011, Dr. McMillan has been a business mentor in the Department of Chemical Engineering, or the Department, at Northeastern University and has served on the Department's Industrial Advisory Board since 2010. He has authored or co-authored more than 75 presentations and publications. Dr. McMillan holds Master’s Degree in Economics and B.S. in Chemical Engineering from the University of Delaware and a Ph.D. in Chemical Engineering from the Georgia Institute of Technology  

Research Interest

 chemical engineering